Peroxisome proliferator-activated receptors and retinoic acid receptors differentially control the interactions of retinoid X receptor heterodimers with ligands, coactivators, and corepressors

被引:237
|
作者
DiRenzo, J
Soderstrom, M
Kurokawa, R
Ogliastro, MH
Ricote, M
Ingrey, S
Horlein, A
Rosenfeld, MG
Glass, CK
机构
[1] UNIV CALIF SAN DIEGO, DEPT MED, DIV CELLULAR & MOL MED, LA JOLLA, CA 92093 USA
[2] UNIV CALIF SAN DIEGO, DEPT MED, DIV ENDOCRINOL & METAB, LA JOLLA, CA 92093 USA
[3] UNIV CALIF SAN DIEGO, HOWARD HUGHES MED INST, LA JOLLA, CA 92093 USA
关键词
D O I
10.1128/MCB.17.4.2166
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
As the obligate member of most nuclear receptor heterodimers, retinoid X receptors (RXRs) can potentially perform two functions: cooperative binding to hormone response elements and coordinate regulation of target genes by RXR ligands, In this paper we describe allosteric interactions between RXR and two heterodimeric partners, retinoic acid receptors (RARs) and peroxisome proliferator-activated receptors (PPARs); RARs and PPARs prevent and permit activation by RXR-specific ligands, respectively, By competing for dimerization with RXR on response elements consisting of direct-repeat half-sites spaced by 1 bp (DRL elements), the relative abundance of RAR and PPAR determines whether the RXR signaling pathway will be functional. In contrast to RAR, which prevents the binding of RXR ligands and recruits the nuclear receptor corepressor N-CoR, PPAR permits the binding of SRC-1 in response to both RXR and PPAR ligands, Overexpression of SRC-I markedly potentiates ligand-dependent transcription by PPAR gamma, suggesting that SRC-I serves as a coactivator in vivo, Remarkably, the ability of RAR to both block the binding of ligands to RXR and interact with corepressors requires the CoR box, a structural motif residing in the N-terminal region of the RAR ligand binding domain, Mutations in the CoR box convert RAR from a nonpermissive to a permissive partner of RXR signaling on DR1 elements. We suggest that the differential recruitment of coactivators and corepressors by RAR-RXR and PPAR-RXR heterodimers provides the basis for a transcriptional switch that may be important in controlling complex programs of gene expression, such as adipocyte differentiation.
引用
收藏
页码:2166 / 2176
页数:11
相关论文
共 50 条
  • [31] Peroxisome proliferator-activated receptors ligands and ischemia-reperfusion injury
    Di Paola, Rosanna
    Cuzzocrea, Salvatore
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2007, 375 (03) : 157 - 175
  • [32] Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications - a review
    Grygiel-Gorniak, Bogna
    NUTRITION JOURNAL, 2014, 13
  • [34] Evaluation of synthetic sphingolipid analogs as ligands for peroxisome proliferator-activated receptors
    Tsuji, Kiyomi
    Satoh, Shigeru
    Mitsutake, Susumu
    Murakami, Itsuo
    Murakami, Itsuo
    Park, Jeong-Ju
    Li, Qian
    Chang, Young-Tae
    Chung, Sung-Kee
    Igarashi, Yasuyuki
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (06) : 1643 - 1646
  • [35] Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications - a review
    Bogna Grygiel-Górniak
    Nutrition Journal, 13
  • [36] Peroxisome proliferator-activated receptors ligands and ischemia-reperfusion injury
    Rosanna Di Paola
    Salvatore Cuzzocrea
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2007, 375 : 157 - 175
  • [37] Proinflammatory cytokine and ligands modulate cardiac peroxisome proliferator-activated receptors
    Lee, T-I.
    Kao, Y-H.
    Chen, Y-C.
    Chen, Y-J.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2009, 39 (01) : 23 - 30
  • [38] The role of various peroxisome proliferator-activated receptors and their ligands in clinical practice
    Derosa, Giuseppe
    Sahebkar, Amirhossein
    Maffioli, Pamela
    JOURNAL OF CELLULAR PHYSIOLOGY, 2018, 233 (01) : 153 - 161
  • [39] Comparative Evaluation of Gemcabene and Peroxisome Proliferator-Activated Receptor Ligands in Transcriptional Assays of Peroxisome Proliferator-Activated Receptors: Implication for the Treatment of Hyperlipidemia and Cardiovascular Disease
    Bisgaier, Charles L.
    Oniciu, Daniela C.
    Srivastava, Rai Ajit K.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2018, 72 (01) : 3 - 10
  • [40] Peroxisome proliferator-activated receptors (PPARs) in the control of bone metabolism
    Giaginis, Costas
    Tsantili-Kakoulidou, Anna
    Theocharis, Stamatios
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2007, 21 (03) : 231 - 244